Gearing AI to Fight Pandemics: a Novel COVID-19 Drug Candidate Announced
Hong Kong-based clinical stage drug discovery company Insilico Medicine just announced the nomination of a novel preclinical drug candidate for …
All Posts
The Promise of Next-Generation Proteomics in Revolutionizing Cancer Research and Treatment
Artificial intelligence (AI) is undoubtedly a big deal in the pharmaceutical industry, bringing the unprecedented abilities of modeling biology at …
Meet the Company Using Artificial Intelligence for Designing Targeted Protein Degraders
Proteins are essential components of living matter – they function as building blocks for cells and tissues, as well as …
7 Biotechs Fighting Rare Diseases With Gene-Editing Tech
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases …
Better Data Management is Key for Clinical Trials: Interview with Raj Indupuri, CEO, eClinical Solutions
The digitalization of clinical trials and the adoption of artificial intelligence (AI) has been a hot topic for a number …
Choosing The Right CRO For Pharma R&D Outsourcing
This post was originally published on Quora, answering the question: "How do drug manufacturers select the right contract research organization(CRO)?" …
Merging AI and Quantum Computing To Boost Drug Discovery
Quantum computing is a growing trend due to recent major advances in hardware making this technology a practically feasible thing. …
How Pharmaceutical Industry Is Adopting Artificial Intelligence To Boost Drug Research
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
This South Korean Company is at the Forefront of AI-driven Drug Discovery
There is a new generation of tech-savvy drug discovery companies, applying the power of artificial intelligence (AI) to accelerate and …
Targeted Protein Degradation: a New Approach to Small Molecule Therapeutics
There is a new wave of innovation that is sweeping through pharmaceutical drug discovery: targeted protein degradation (TPD). TPD is …
The Evolving Culture of Biotech Entrepreneurship
Dr. Tony Kulesa is the co-founder of Petri, an organization that both invests in early-stage biotech startups and works 1-on-1 …
Combining AI and Quantum Mechanics to Improve Drug and Vaccine Discovery
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years …